The invention discloses a hemostatic composition comprising crosslinked gelatin in particulate form suitable for use in hemostasis wherein the composition is present in paste form containing 15.0 to 19.5% (w/w) preferably 16.0 to 19.5% (w/w) 16.5 to 19.5% (w/w) 7.0 to 18.5% (w/w)or 17.5 to 18.5% (w/w) more preferred 16.5 to 19.0% (w/w)or16.8 to 7.8% (w/w) especially preferred 16.5 to 17.5% (w/w) and wherein the composition comprises an extrusion enhancer.
